Ιρλανδία -
Αγγλικά -
HPRA (Health Products Regulatory Authority)
vasogen %w/w cream
forest laboratories uk ltd - dimeticone zinc oxide calamine - cream - %w/w
Ηνωμένο Βασίλειο -
Αγγλικά -
MHRA (Medicines & Healthcare Products Regulatory Agency)
conotrane cream
evolan pharma ab - dimeticone; benzalkonium chloride - cutaneous cream - 220mg/1gram ; 1mg/1gram
Ηνωμένο Βασίλειο -
Αγγλικά -
MHRA (Medicines & Healthcare Products Regulatory Agency)
siopel cream
derma uk ltd - dimeticone 1000; cetrimide - cutaneous cream - 100mg/1gram ; 3mg/1gram
Ηνωμένο Βασίλειο -
Αγγλικά -
MHRA (Medicines & Healthcare Products Regulatory Agency)
cymex cream
dexcel-pharma ltd - dimeticone; urea; cetrimide; chlorocresol - cutaneous cream - 90mg/1gram ; 10mg/1gram ; 5mg/1gram ; 1mg/1gram
Ηνωμένο Βασίλειο -
Αγγλικά -
MHRA (Medicines & Healthcare Products Regulatory Agency)
hedrin 4% lotion
thornton & ross ltd - dimeticone - cutaneous solution - 40mg/1gram
Ηνωμένο Βασίλειο -
Αγγλικά -
MHRA (Medicines & Healthcare Products Regulatory Agency)
boots lip & cold sore cream
the boots company plc - dimeticone; urea; cetrimide; chlorocresol - cutaneous cream - 90mg/1gram ; 10mg/1gram ; 5mg/1gram ; 1mg/1gram
Ιρλανδία -
Αγγλικά -
HPRA (Health Products Regulatory Authority)
dentinox infant colic drops 21 mg/2.5 ml oral suspension
phoenix labs - dimeticone, activated - oral suspension - 21 mg/ 2.5 millilitre(s) - other drugs for functional gastrointestinal disorders; silicones
Ιρλανδία -
Αγγλικά -
HPRA (Health Products Regulatory Authority)
asilone oral suspension
seton products ltd - magnesium oxidum leve aluminium hydroxide dimethicone 350 - oral suspension
Ιρλανδία -
Αγγλικά -
HPRA (Health Products Regulatory Authority)
asilone antacid liquid
seton products ltd - magnesium oxidum leve aluminium hydroxide dimethicone 350 - oral suspension
Αυστραλία -
Αγγλικά -
Department of Health (Therapeutic Goods Administration)
tasigna nilotinib 200 mg capsules blister pack
novartis pharmaceuticals australia pty ltd - nilotinib hydrochloride monohydrate, quantity: 220.6 mg (equivalent: nilotinib, qty 200 mg) - capsule, hard - excipient ingredients: magnesium stearate; crospovidone; titanium dioxide; iron oxide yellow; poloxamer; gelatin; lactose monohydrate; colloidal anhydrous silica; propylene glycol; butan-1-ol; isopropyl alcohol; purified water; shellac; iron oxide red; ethanol absolute; potassium hydroxide; ammonia; industrial methylated spirit; iron oxide black; sulfuric acid; lecithin; xanthan gum; benzoic acid; sorbic acid; methylcellulose; polyethylene glycol; silica dimethicone silylate; dimeticone - tasigna is indicated for the:,? treatment of adult patients with newly diagnosed philadelphia chromosome positive chronic myeloid leukaemia (cml) in chronic phase. ? treatment of adults with chronic phase and accelerated phase philadelphia chromosome positive chronic myeloid leukaemia (cml) resistant to or intolerant of prior therapy including imatinib.